ReviewMedicina (Kaunas, Lithuania)2022
An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant
Abstract readReview
In one paragraph
Review in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Comparative Evaluation of Real-Time PCR, Immunochromatographic Assay, and Modified Carbapenem Inactivation Method for Carbapenemase Detection in Enterobacterales Isolates.International journal of molecular sciences · 2026Article
- Phenotypic and Genetic Characteristics ofInternational journal of molecular sciences · 2026Article
- Susceptibility Trends of Enterobacterales Isolated from Blood Culture Samples: A Four-Year Analysis with the Rise of Carbapenem Resistance.Infectious diseases & clinical microbiology · 2026Article
- Urinary Tract Infections in Children - Microbiological Challenges and Mechanisms of Bacterial Resistance.Maedica · 2026Review
- Silent Threat Evolution: Critically Important Carbapenem and Colistin Resistance Genes in the Natural Aquatic Environment.Antibiotics (Basel, Switzerland) · 2026Review
- Genomic epidemiology of multidrug-resistant and ESBL-producing Proteus mirabilis in a military referral hospital in Ethiopia.PloS one · 2026Article
- Carbapenem-resistant Enterobacterales bacteraemia at a tertiary hospital: A five-year review.Southern African journal of infectious diseases · 2026Article
- Molecular characterization of blaBMC infectious diseases · 2025Article
- Molecular epidemiology and clinical characteristics of carbapenem-resistantMicrobiology spectrum · 2025Article
- A novel gene linked to Imipenem resistance in E. coli isolate lacking known Imipenem-resistance genes.Scientific reports · 2025Article
- Exploring New Delhi Metallo Beta Lactamases in Klebsiella pneumoniae and Escherichia coli: genotypic vs. phenotypic insights.Annals of clinical microbiology and antimicrobials · 2025Article
- High-throughput screening of monoclonal antibodies against carbapenemases using a multiplex protein microarray platform.Frontiers in microbiology · 2025Article
- Promising Future of Novel Beta-Lactam Antibiotics Against Bacterial Resistance.Drug design, development and therapy · 2025Review
- High-Risk Lineages of Hybrid Plasmids Carrying Virulence and Carbapenemase Genes.Antibiotics (Basel, Switzerland) · 2024Article
- Carbapenem-ResistantNanomaterials (Basel, Switzerland) · 2024Article
- Prevalence of carbapenem-resistantSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024Article
- Innovative approaches in phenotypic beta-lactamase detection for personalised infection management.Nature communications · 2024Review
- Cell morphology as biomarker of carbapenem exposure.The Journal of antibiotics · 2024Article
- Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience.Diagnostics (Basel, Switzerland) · 2024Article
- Characterization ofHeliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia.ORCID 0000-0002-6774-9847
Khalid EljaalyDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-8355-8637
Saad AlhumaidAdministration of Pharmaceutical Care, Al-Ahsa Health Cluster, Ministry of Health, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-4552-4513
Hawra AlbayatInfectious Disease Department, King Saud Medical City, Riyadh 7790, Saudi Arabia.
Wasl Al-AdsaniDepartment of Medicine, Infectious Diseases Hospital, Kuwait City 63537, Kuwait.
Amal A SabourDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Maha A AlshiekheidDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Jumana M Al-JishiInternal Medicine Department, Qatif Central Hospital, Qatif 635342, Saudi Arabia.
Faryal KhamisInfection Diseases Unit, Department of Internal Medicine, Royal Hospital, Muscat 1331, Oman.
Sara AlwarthanDepartment of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Ammam 34212, Saudi Arabia.
Mashael AlhajriDepartment of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Ammam 34212, Saudi Arabia.
Amal H AlfarajPediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Abqaiq 33261, Saudi Arabia.
Huseyin TombulogluDepartment of Genetics Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 34221, Saudi Arabia.ORCID 0000-0001-8546-2658
Mohammed GaroutDepartment of Community Medicine and Health Care for Pilgrims, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Duaa M AlabdullahMolecular Diagnostic Laboratory, Dammam Regional Laboratory and Blood Bank, Dammam 31411, Saudi Arabia.
Elmoeiz Ali Elnagi MohammedDepartment of Clinical Laboratory Sciences, Prince Sultan Military College of Health Sciences, Dhahran 34313, Saudi Arabia.
Fatimah S Al YamiDepartment of Medical Laboratory, King Fahad Military Medical Complex, Dhahran 34313, Saudi Arabia.
Haifa A AlmuhtareshDepartment of Clinical Laboratories Services, Dammam Medical Complex, Dammam Health Network, Dammam 5343, Saudi Arabia.
Kovy Arteaga LiviasFacultad de Ciencias de la Salud, Universidad Científica del Sur, Lima 15001, Peru.ORCID 0000-0002-0182-703X
Abbas Al MutairResearch Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.
Shawqi A AlmushrifDepartment of Microbiology and Hematology Laboratory, Dammam Comprehensive Screening Centre, Dammam 31433, Saudi Arabia.
Mai Abdel Haleem A AbusalahFaculty of Medical Allied Science, Zarqa University, Zarqa 13110, Jordan.ORCID 0000-0002-8473-9392
Naveed AhmedDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.ORCID 0000-0003-1504-1705
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improper use of antimicrobials has resulted in the emergence of antimicrobial resistance (AMR), including multi-drug resistance (MDR) among bacteria. Recently, a sudden increase in Carbapenem-resistant
Indexed as
Antimicrobial StewardshipCarbapenemsAnti-Bacterial AgentsColistinGenotypeHumansAnti-Bacterial AgentsCarbapenemsColistinantibiotic resistanceCarbapenemcarbapenemaseEnterobacteralesEnterobacteriaceaeMDRmulti-drug resistanceβ-lactamase
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.